Utilisation and Safety of Low Molecular Weight HeparinsProspective Observational Study in Medical Inpatients

被引：0
|
作者：
Philippe Cestac
Haleh Bagheri
Maryse Lapeyre-Mestre
Pierre Sié
Atoussa Fouladi
Eric Maupas
Philippe Léger
Bernard Fontan
Patrice Massip
Jean-Louis Montastruc
机构：
[1] Faculté de Médecine,Department of Clinical Pharmacology, Centre Midi
[2] Purpan University Hospital,Pyrénées de Pharmacovigilance, de Pharmacoépidémiologie et d’Informations sur le Médicament
[3] Purpan University Hospital,Laboratory of Haematology
[4] Purpan University Hospital,Department of Cardiology
[5] Purpan-Casselardit University Hospital,Department of Angiology
[6] Purpan University Hospital,Department of Geriatrics
来源：
Drug Safety | 2003年 / 26卷
关键词：
Renal Insufficiency; Enoxaparin; Deep Venous Thrombosis; Oral Anticoagulant; Thrombocytosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Aims: Low molecular weight heparins (LMWHs) are widely used as curative or preventive treatments of thromboembolic diseases. The aim of our study was to: (i) investigate the pattern of prescription of LMWHs in different departments of French teaching hospitals; and (ii) estimate the incidence of adverse drug reactions (ADRs) induced by LMWHs and associated risk factors for the occurrence of bleeding events.
引用
收藏
页码：197 / 207
页数：10
相关论文
共 50 条
  • [21] Observational Study to Evaluate Efficacy and Safety of Vidaslim®, a Medical Nutrition Therapy, for Weight Loss in Subjects with Obesity
    Kalra, Sanjay
    Kapoor, Nitin
    Joseph, Jeevan
    Arun, Abhishek
    Bhattacharyya, Supratik
    Dalai, Siba Prasad
    NUTRITION AND DIETARY SUPPLEMENTS, 2024, 16 : 27 - 35
  • [22] Utilisation and Safety of Deferasirox (Exjade®): Results from an Observational Cohort Study in England
    Osborne, V.
    Davies, M.
    Layton, D.
    Shakir, S.
    DRUG SAFETY, 2015, 38 (10) : 1026 - 1027
  • [23] Utilisation and Safety of Deferasirox (Exjade®): Results from an Observational Cohort Study in England
    Osborne, Vicki
    Davies, Miranda
    Layton, Deborah
    Shakir, Saad A. W.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2015, 24 : 77 - 77
  • [24] Iron homeostasis in inflammation A single centre prospective observational study in medical inpatients
    Chrobak, Carl
    Sidler, Jan A.
    O'Meara, Alix
    Schadelin, Sabine
    Hug, Balthasar L.
    SWISS MEDICAL WEEKLY, 2017, 147
  • [25] Adverse Drug Reactions in Children Medical Inpatients in Mali: Prospective Observational Study
    Oumar, A. A.
    Katile, D.
    Toure, A.
    Ba, S.
    Sylla, M.
    Dao, S.
    DRUG SAFETY, 2010, 33 (10) : 909 - 909
  • [26] EFFICIENCY AND SAFETY OF LOW-MOLECULAR-WEIGHT HEPARIN
    ENCKE, A
    LANGENBECKS ARCHIV FUR CHIRURGIE, 1992, 377 (05): : 257 - 257
  • [27] LOW-MOLECULAR-WEIGHT HEPARIN - EFFICACY AND SAFETY
    FRADE, LJG
    REVISTA CLINICA ESPANOLA, 1994, 194 : 442 - 448
  • [28] A controlled cohort study on the use and safety of low molecular weight heparin during pregnancy
    Galambosi, P. J.
    Ulander, V-M
    Kaaja, R. J.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 445 - 445
  • [29] Utilisation of prehospital emergency medical services for hyperglycaemia: A community-based observational study
    Villani, Melanie
    Nanayakkara, Natalie
    Ranasinha, Sanjeeva
    Earnest, Arul
    Smith, Karen
    Soldatos, Georgia
    Teede, Helena
    Zoungas, Sophia
    PLOS ONE, 2017, 12 (08):
  • [30] Retrospective database analysis of the prevention of venous thromboembolism with low-molecular-weight heparin in acutely ill medical inpatients in community practice
    McGarry, LJ
    Thompson, D
    CLINICAL THERAPEUTICS, 2004, 26 (03) : 419 - 430
12345